Stock comparison
Becton, Dickinson and
Harmony Biosciences Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BDX
Becton, Dickinson and
Market cap
$53.49B
Sector
Healthcare
HRMY
Harmony Biosciences Holdings
Market cap
$1.75B
Sector
Healthcare
Overall winner
Harmony Biosciences Holdings HRMY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BDX | HRMY | Winner |
|---|---|---|---|
| Warren Buffett | 49D | 67B | HRMY |
| Benjamin Graham | 57C | 60C | HRMY |
| Philip Fisher | 36D | 75B | HRMY |
| Peter Lynch | 15F | 62C | HRMY |
| Joel Greenblatt | 40D | 28F | BDX |
| Charlie Munger | 39D | 62C | HRMY |
| Terry Smith | 39D | 67B | HRMY |
Side-by-side metrics
| Metric | BDX | HRMY |
|---|---|---|
| Market cap | $53.49B | $1.75B |
| P/E (TTM) | 35.3x | 11.8x |
| EV/EBIT | 26.5x | 6.4x |
| ROIC (TTM) | 4.1% | 12.5% |
| Gross margin | 46.48% | 76.55% |
| Net margin | 5.33% | 16.2% |
| Revenue CAGR 5y | 3.37% | 29.85% |
| EPS CAGR 5y | -4.15% | 46.45% |
| Debt / Equity | 0.7x | 0.2x |
| Dividend yield | 2.45% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BDX leads on
- Dividend yield2.45%vs 0.0%+100%
- Market cap$53.49Bvs $1.75B+97%
HRMY leads on
- EPS CAGR 5y46.45%vs -4.15%+109%
- Revenue CAGR 5y29.85%vs 3.37%+89%
- EV/EBIT6.4xvs 26.5x+76%
- Debt / Equity0.2xvs 0.7x+68%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.